As a new physician assistant in 2007, Erika Jacumin, PA-C, saw firsthand the enormous impact deep brain stimulation (DBS) could have on the lives of people living with Parkinson’s disease. Now, she’s helping to manage patients with Parkinson’s disease and other movement disorders in our Morreene Road Clinic. For this week’s “Spotlight” interview, Jacumin talks to us about her previous work helping patients with movement disorders.
Clinical research is an integral part of developing, testing, and refining new therapies. As one of our Clinical Research Coordinators Vera George is responsible for making sure dozens of these studies at Duke run smoothly and efficiently. For this week’s “Spotlight” interview, George talks to us about the joys of helping current and future patients with myasthenia gravis, movement disorders, and other conditions.
This March, members of our Department contributed to studies that reveal potential new therapeutic targets for Alzheimer’s disease, help triage patients suffering from traumatic brain injury, address issues contributing to physician burnout, and more. In all, our faculty, staff, students, and trainees contributed to 15 studies published over the past 31 days. Read about them and find links to the original articles below.
Parkinson’s and Movement Disorders
Professionally, Clare Essex lives in two worlds. Within the lab of Laurie Sanders, PhD, and Carol Colton, PhD, in the Duke Neurology Department, she’s working part-time to improve understandings the genetic underpinnings of neurodegenerative disease. Essex spends the other half of her work week as a medical scribe at UNC REX Hospital in Raleigh.
The first month of 2022 saw the publication of 18 new peer-reviewed journal articles from members of the Duke Neurology Department. Highlights include a new article in Lancet Neurology discussing the epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders, case reports describing the progression and treatment options for rare neurological conditions, and a summary of how the first year of the COVID-19 pandemic affects neurology residency programs in the United States.
Research authored by members of the Duke Neurology Department published during the final month of 2021 advanced our knowledge of stroke, epilepsy, dystonia, and other conditions.
Members of the Duke Neurology Department contributed to 14 new peer-reviewed journal articles written this November. Highlights include an analysis of fragmentation within the delivery of neurological health care, an examination of racial disparities in the use of telehealth, and a discussion of the best ways to use social medicine to share news on epilepsy and clinical neurophysiology. Read the paragraphs below for short summaries of each of these 14 articles, as well as links to the original entries themselves.
As an undergraduate, Miranda Shipman studied drawing and painting, teaching art and managing a gallery until she developed a rare brain tumor. After she had the tumor removed, Shipman developed a passion for neuroscience, with the hope of helping to discover new treatments. Now she’s helping to do just that in the lab of Nicole Calakos, MD, PhD, where she’s screening compounds to help people living with dystonia.
Researchers at Duke University School of Medicine have been selected to lead two inter-institution team grants totaling $18 million to investigate Parkinson’s disease.
The awards from the Aligning Science Across Parkinson’s (ASAP) initiative position Duke as a national leader in understanding the origins and development of this devastating movement disorder.
New research from the Duke Neurology Department provided insights into our ability to improve patient care and better understand neurological conditions. The 11 studies featuring our faculty, staff, and trainees published this September include the discovery of an HIV medication’s surprising potential to treat dystonia, an analysis of brain tumor patients admitted to intensive care, and a personal story of one faculty member’s grandfather, who lived through the ups and downs of a century of health care in the United States.